Gas gangrene caused by Clostridium species — commonly referred to as clostridial myonecrosis — is a rapidly progressive, life-threatening soft-tissue infection that demands immediate action. This page summarises the clinical scenario and treatment goals; the complete structured regimen is accessible via the link below.
Gas gangrene falls into clostridial and non-clostridial forms depending on the causative organism. Clostridium species are the most common cause of gas gangrene, which is why the condition is also termed clostridial myonecrosis. This protocol addresses the clostridial form specifically.
Management requires immediate, comprehensive intervention combining aggressive surgical treatment of all involved tissue with infection-targeted therapies and intensive systemic support. Multiple simultaneous components are involved — the full sequence, specific agents, and clinical parameters are defined in the complete protocol.
Arrest of the infective process and limitation of the extent of tissue necrosis, with conservation of a functional limb.
DOI: 10.1002/14651858.CD010577.pub2
Gas gangrene can be grouped into clostridial and non-clostridial forms, depending on the type of bacteria causing the infection.
Gas gangrene is also called 'clostridial myonecrosis' because Clostridium species are the most common cause of the infection.
Once gas gangrene is suspected, an aggressive debridement of all tissues involved should be carried out immediately for early diagnosis and treatment.
Early surgical intervention with multiple incisions and fasciotomy (incisions that are left open to relieve underlying pressure in the tissues) involves the removal of all compromised tissue, foreign material and haematoma (collections of blood) to allow decompression and drainage.
While myositis is still relatively localised, radical decompression of the fascial compartments involved usually arrests the process, and eliminates the need for amputation in order to conserve a functional limb.
View source ↗